Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial

Stroke Reports Thursday, April 3rd, 2014

MAR 18, 2014

  1. Conflict of interest: Dr. Conrado J. Estol and Ms. Renee Hebert Martin have nothing to disclose. Dr. Philip M. W. Bath received consulting fees from Boehringer Ingelheim. Dr. Philip B. Gorelick received consulting fees from AstraZenica/Quintiles, Bayer, Janssen, Takeda, Roche/Parexel, Shire, Brainsgate, and D-Pharm, and lecture fees from Boehringer Ingelheim. Mr. Daniel Cotton is an employee of Boehringer Ingelheim.

  2. The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors and were fully responsible for all content and editorial decisions, and were involved at all stages of manuscript development. The authors received no compensation related to the development of the manuscript. This work was supported by Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI). BIPI was given the opportunity to check the data used in the manuscript for factual accuracy only. Read More

Sign Up Now
National Minority Quality Forum Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2012 National Minority Quality Forum, Inc. All Rights Reserved.